Latest Publications

Share:

Prescription Drugs: Executive Order Aims to Lower Prices

On April 15, 2025, President Trump signed an executive order (EO) with the aim of reducing the cost of prescription drugs....more

Health Policy: Expected Movements in the Lame Duck Session – November/December 2024

Congress returned to Washington this week with just five weeks left in this year’s legislative calendar. With a Continuing Resolution (CR) that expires December 20, 2024, either a year-end spending package or a new Continuing...more

New Biden EO on AI Oversight, Development, and Use: Implications for the Health Care Industry

On Monday, October 30, President Biden signed an executive order (EO) aimed at overhauling the governance and oversight of artificial intelligence (AI) and technological infrastructure, including setting standards for AI used...more

Priorities of the 118th Congress and the Biden Administration

As the final votes of the 2022 Midterm Elections are counted, Republicans have taken back control of the House of Representatives, while the Democrats will retain control of the Senate. Both chambers will be held by extremely...more

The Results Are In... A Recap of the 2022 Midterm Elections and a Preview of the Lame-Duck Session

Votes in the 2022 Midterm Elections are still being tallied. It will likely take several more days, if not weeks, to be able to confirm who will hold the majority in the House and Senate.Please note that House, Senate, and...more

What’s Next in Washington? - October 2022 Edition

The 2022 Midterm Elections are a little over one month away and the races are tightening up. Democrats have seen their fortunes improve with a string of legislative victories and improving poll numbers for President Joe...more

FDA User Fee Programs: Congress Contemplates a Clean Reauthorization in the Continuing Resolution

The Food and Drug Administration’s (FDA) user fee programs, which pay the salaries of agency staff who review drug and medical device applications, are set to expire on October 1, 2022. These include the Prescription Drug...more

What’s Next in Washington? - September 2022 Edition

As September gets underway and Washington returns from a busy recess, important deadlines loom. August saw the introduction and passage of the Inflation Reduction Act, the Biden Administration’s announcement of student debt...more

The Inflation Reduction Act of 2022: Medicare Drug Pricing Provisions Will Change the Health Care Industry

President Biden has now signed into law the $700 billion Inflation Reduction Act of 2022, a package comprised of health care, climate change, and taxation policy reforms. It is a scaled-back version of the Build Back Better...more

What’s Next in Washington? - July Edition

With just a few short weeks left until August recess, there is no shortage of items on the congressional to-do list. The latest round of Supreme Court decisions has inspired new action within Congress to pass legislation...more

What’s Next in Washington? - May 2022 Edition

Congress recently returned from its two-week recess with an extensive to-do list. Between now and the August recess, the House will be in session for a total of 32 legislative days, and the Senate will be in for 54...more

What’s Next in Washington? - April 2022

While Congress has a two-week recess in April, there are many priority items on the agenda this month. Less than two weeks after signing the Fiscal Year (FY) 2022 spending package, President Biden released his budget for FY...more

Update: What to Know About PREVENT Pandemics Act Following March 15 Committee Markup

On March 15, 2022, the Senate Health, Education, Labor and Pensions Committee (HELP) held a full committee markup to offer several amendments and vote on S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New...more

March Is Here, so What’s Next in Washington?

The first day of spring is right around the corner and so are deadlines for congressional appropriations requests. This month, lawmakers are racing against the clock to fund the government and President Biden looks to...more

The Biden Administration Looks to Push Regulatory Change in 2022

The first year of the Biden Administration marked the passage of major spending packages, including the American Rescue Plan and the Infrastructure Investment and Jobs Act. Yet, with President Biden’s social spending package,...more

Senate HELP Committee’s PREVENT Pandemics Act Draft Released: What to Know

Following nearly a year of committee hearings, research, policy briefs, and discussion with agency experts, the Senate Health, Education, Labor, and Pensions (HELP) Committee Chairwoman Patty Murray (D-WA) and Ranking Member...more

What’s Next in Washington? – February

Despite February being a short month, various proposals are still on the table. As Congress returns from recess this week, it faces a daunting to-do list. Government funding runs out by mid-February, Democrats are looking for...more

Congressional Map Redistricted in California: What to Know

Late last month, California Secretary of State Shirley Weber signed off on new congressional and state legislative maps based on an updated population count from the 2020 census. An independent redistricting commission for...more

1/13/2022  /  California , Redistricting

What’s Next in Washington?

As Congress returns from its holiday recess, January is shaping up to be a busy month in Washington, and 2022 will prove to be just as eventful. See below on what awaits Congress, and the upcoming agenda the Foley Federal...more

The Proposed Cures 2.0 Act – What You Can Expect

On November 16, 2021, U.S. House Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) introduced the highly anticipated Cures 2.0 Act (H.R. 6000). Among other things, this 173-page bipartisan bill contain provisions to...more

What You Need to Know about President Trump’s Executive Order to Strengthen the Domestic Supply Chain for Essential Drugs and...

On August 6, 2020, President Trump signed an Executive Order (“Order”) to ensure essential medicines, medical countermeasures, and critical inputs are made in the United States. The President recognized that reliable...more

Congressional Coronavirus Relief Package, Phase Four

The House and Senate returned to Washington July 20, and a second Coronavirus Relief Package is at the top of the agenda. Passed in late May on party-line voting, the House Democrats' HEROES Act would provide over $3.5...more

Accepting CARES Act Assistance: Congressional and Other Investigative Risks

While recent federal funding has provided a lifeline for some companies, accepting government assistance under the CARES Act also carries significant legal, political and reputational risks for recipients. Loans are the tip...more

58 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide